Cargando…
Considerations in Understanding Vaccine Effectiveness
Although vaccine effectiveness reports are essential to assessing policies on SARS-CoV-2 vaccination, several factors can affect our interpretation of the results. These include the waning of antibodies, the prevailing viral variants at the time of the study, and COVID-19 disease prevalence in the p...
Autores principales: | Lau, Chin Shern, Aw, Tar Choon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864852/ https://www.ncbi.nlm.nih.gov/pubmed/36679865 http://dx.doi.org/10.3390/vaccines11010020 |
Ejemplares similares
-
Disease Prevalence Matters: Challenge for SARS-CoV-2 Testing
por: Lau, Chin-Shern, et al.
Publicado: (2021) -
SARS-CoV-2 Antigen Testing Intervals: Twice or Thrice a Week?
por: Lau, Chin Shern, et al.
Publicado: (2022) -
210-Day Kinetics of Total, IgG, and Neutralizing Spike Antibodies across a Course of 3 Doses of BNT162b2 mRNA Vaccine
por: Lau, Chin Shern, et al.
Publicado: (2022) -
SARS-CoV-2 Spike and Neutralizing Antibody Kinetics 90 Days after Three Doses of BNT162b2 mRNA COVID-19 Vaccine in Singapore
por: Lau, Chin Shern, et al.
Publicado: (2022) -
Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine
por: Lau, Chin-Shern, et al.
Publicado: (2021)